Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class.
Compared with DPP-4 inhibitors, patients...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Endocrinology | PET Scan | Study | Thyroid | Thyroid Cancer | Urology & Nephrology